| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2510 |
| Trial ID | NCT04637763 |
| Disease | Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CB-010 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma |
| Year | 2020 |
| Country | United States |
| Company sponsor | Caribou Biosciences, Inc. |
| Other ID(s) | CB10A |
| Cohort 1 | |||||||||||
|
|||||||||||